Bayer CropScience announced an interim dividend of ₹90 per equity share. The company’s Q2 revenue from operations was ₹15,534 million, and profit for the period was ₹1,527 million. The Board has approved the unaudited financial results for the quarter and half-year ended September 30, 2025. The interim dividend will be paid on December 3, 2025, to shareholders on record as of November 14, 2025.
Interim Dividend Announcement
The Board of Directors of Bayer CropScience has declared an interim dividend of ₹90 per equity share (face value of ₹10 each) for the financial year 2025-26. This decision, made at the meeting on November 7, 2025, will result in a total payout of ₹4,045 million. The dividend will be paid on Wednesday, December 3, 2025, to shareholders whose names appear on the Register of Members as on the record date, Friday, November 14, 2025.
Financial Performance: Q2 2025-26
Bayer CropScience’s financial results for Q2 (July-September) 2025 show a revenue from operations of ₹15,534 million, compared to ₹17,382 million for Q2 of the previous year. The company’s total income for the quarter stood at ₹15,672 million. Profit before tax was ₹2,003 million and the profit for the period was ₹1,527 million.
Half-Year Performance
For the half-year ended September 30, 2025, Bayer CropScience reported revenue from operations of ₹34,680 million. The profit before tax for the same period amounted to ₹5,355 million, and the profit for the period was ₹4,314 million.
Key Financial Figures (₹ in Millions)
Key highlights from the unaudited financial results include:
- Revenue from Operations: ₹15,534 (Q2 2025)
- Total Income: ₹15,672 (Q2 2025)
- Profit Before Tax: ₹2,003 (Q2 2025)
- Profit for the period: ₹1,527 (Q2 2025)
Source: BSE
